{"SPADE_UN_15817": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_15817", "Peptide Name": "FGR (7-22)-X13, FGF-X13", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "AAVALLPAVLLALLAPMPFSTGKRIMLGE", "Sequence Length": 29, "UniProt Entry": ["http://www.uniprot.org/uniprot/P08620"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:OCI-AML3 (Not active up to 100 µM)", "Hemolytic Activity": "Not available", "Cytotoxicity": "HEK293:Not active up to 100 µM; HFF:Not active up to 100 µM", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C138H235N33O34S2", "Mass": 2964.67, "PI": 8.79, "Net Charge": 1, "Hydrophobicity": 1.31, "Half Life": "Mammalian:4.4 hourYeast:>20 hourE.coli:>10 hour", "Literature": [{"Title": "Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy", "Pubmed ID": "26734838", "Reference": "Oncotarget. 2016 Feb 2;7(5)5483-94.", "Author": "Neo SH, Lew QJ, Koh SM, Zheng L, Bi X, Chao SH.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=26734838"}], "Frequent Amino Acids": "LAP", "Absent Amino Acids": "CDHNOQUWY", "Basic Residues": 2, "Acidic Residues": 1, "Hydrophobic Residues": 22, "Polar Residues": 12, "Positive Residues": 2, "Negative Residues": 1, "Similar Sequences": [{"SPADE_ID": "SPADE_N_05030", "Similarity": 1.0, "Sequence": "AAVALLPAVLLALLAP"}, {"SPADE_ID": "SPADE_UN_09658", "Similarity": 1.0, "Sequence": "RRKKAAVALLPAVLLALLAP"}, {"SPADE_ID": "SPADE_UN_09671", "Similarity": 1.0, "Sequence": "RRKKAAVALLP"}]}}}